Wyeth, DHL Enter Logistics Partnership

DHL and Wyeth Pharmaceuticals have entered a multi-year strategic agreement for the logistics coordination of Wyeth’s global clinical trial materials distribution. This agreement marks the first time one logistics provider has been chosen for oversight of clinical trial logistics material shipments and processes throughout multiple distribution channels worldwide.

The two companies will create a closed-loop clinical trial materials supply chain to streamline track and trace capabilities, financial and performance indicators and operational process flows. The agreement includes global distribution by DHL of clinical materials and a framework for warehousing solutions.

“We believe this unique collaboration has the potential to reduce the logistical complexity of our clinical trial operations by providing a leading global infrastructure, and expertise in logistics solutions within the life science industry, ” says Ira Spector, vice president, vice chief of operations clinical development operations, Wyeth Research. “Our goal is for DHL to significantly streamline our clinical trials logistics operations, improve Wyeth’s clinical trial logistical analysis and rationalization of related warehouse optimization, and encompass services provided to our research organization, as well as Wyeth’s third party service providers.”

“DHL is uniquely suited to manage the entire supply chain and distribution needs for the life sciences industry, improving the handling quality, data integrity, and overall supply chain processes that facilitate the development of life-saving and enhancing medicines,” said Angelos Orfanos, vice president of Americas sales, life sciences and healthcare, for DHL Global Customer Solutions. “Wyeth is the kind of global customer that our full-scale technology platform was developed for, enabling each step of medical material transfer to be visible and monitored from product development to trial to consumption.”